SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading

SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading

Dec 20, 2022

The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in connection with providing misleading information to shareholders about the progress of a clinical research treatment…

Full report at: Read More

More News

Sufferers May Look Fine, But Traumatic Brain Injury Takes Its Toll

44 Percent Of Adverse Events In Hospitals Are Preventable, Indicates Cleveland Medical Malpractice Lawyer

Wrong-Way Crash on U.S. 69 Kills Two

OSHA to hold online meeting of the National Advisory Committee on Occupational Safety and Health on Jan. 10, 2023

Distracted Driving Is Shown To Cause More Severe Accidents

LOFTID Inflatable Heat Shield Test A Success, Early Results Show

NASA Awards Contract for Refuse and Recycling Services

FROM:

Volkswagen and Atlas Sport Class Action Settlement: Important Information for Owners and Lessees

FROM: ,

NASA Ames Recognizes Representative Eshoo for Her 32 Years of Service

FROM:

Biden-Harris Administration Announces Sunnyvale, CA as Expected Location for Second CHIPS for America R&D Flagship Facility

FROM: